2017 Fiscal Year Research-status Report
Attitudes towards and acceptance of HPV vaccine in Japanese mothers of adolescents living in the UK and Australia
| Project/Area Number |
16K15367
|
|---|
| Research Institution | Hokkaido University |
|---|
Principal Investigator |
Hanley Sharon 北海道大学, 医学研究院, 特任講師 (80529412)
|
|---|
| Project Period (FY) |
2016-04-01 – 2019-03-31
|
| Keywords | HPV Vaccine / public health / vaccine hesitancy / coverage / education / international comparison / cervical cancer / vaccine confidence |
|---|
| Outline of Annual Research Achievements |
While there is robust evidence to suggest HPV vaccines are safe and effective, conveying the immense depth of scientific knowledge that supports the remarkable safety, efficacy and effectiveness of the HPV vaccines can be difficult. This is particularly the case in this age of social media, alternative facts and fake news, where unscientific, anti-vaccination claims travel quickly and can no longer be ignored. Unconfirmed reports of adverse events following immunization (AEFI) can lead to significant public anxiety. Events in Japan, Columbia, Denmark and now Ireland have illustrated the vulnerability of HPV vaccine uptake to perceptions of risk. In order to help both the general public and health care professionals understand the global situation of the HPV vaccine, three international symposium were held. International experts from countries who have implemented successful HPV vaccination programmes (Bhutan, Malaysia, Australia and the UK) as well as those from countries who are struggling (Denmark, Ireland and Japan) were invited. The first symposium was held at the WCE 2017 in Omiya, the second symposium, aimed at the media, was held at the Institute for Global Health Policy Research in Shinjuku and the third symposium was held in Hokkaido University, Sapporo. By sharing experiences and providing evidence based guidance on key technical and strategic issues, we hoped to present lessons learnt for other countries should they face similar difficulties, propose strategies to counter vaccination hesitancy and try and find a way forward for those countries still struggling.
|
| Current Status of Research Progress |
Current Status of Research Progress
2: Research has progressed on the whole more than it was originally planned.
Reason
The principle researcher met with academics from Sydney University while at a symposium on Vaccine Confidence in London. It was suggested that the Japanese School in Sydney would be a good target population to get information on Japanese mothers' living abroad attitudes to the HPV vaccine.
In London we could not get any cooperation from the Japanese School, but did identify newsletters and mothers groups that might facilitate a way to implement the survey.
|
| Strategy for Future Research Activity |
We are preparing the IRB applications both in Japanese and English to submit to the relevant institutions and hope to start the survey by June 2018.
The results will be presented at both international and national meetings, and published in the relevant international literature.
|
| Causes of Carryover |
理由:I was invited to give a presentation at EUROGIN 2017, They paid for part of the accommodation which I had already budgeted for.
使用計画:I will use this money to attend the IPV 2018 conference in Sydney
|
| Remarks |
Sharon Hanley participated in a short course on Epidemiological Evaluation of Vaccines: Efficacy, Safety and Policy at London School of Hygiene and Tropical Medicine in July 2017
|
